Catheter Precision, Inc.
VTAK · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $226 | $212 | $143 | $149 |
| % Growth | 6.6% | 48.3% | -4% | – |
| Cost of Goods Sold | $546 | $14 | $11 | $11 |
| Gross Profit | -$320 | $198 | $132 | $138 |
| % Margin | -141.6% | 93.4% | 92.3% | 92.6% |
| R&D Expenses | $276 | $2,003 | $222 | $91 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,425 | $2,881 | $3,485 | $3,098 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,701 | $4,884 | $3,707 | $3,189 |
| Operating Income | -$3,021 | -$4,686 | -$3,575 | -$3,051 |
| % Margin | -1,336.7% | -2,210.4% | -2,500% | -2,047.7% |
| Other Income/Exp. Net | $755 | -$1,722 | -$1,194 | $564 |
| Pre-Tax Income | -$2,266 | -$6,408 | -$4,769 | -$2,487 |
| Tax Expense | $78 | -$950 | -$724 | $3,141 |
| Net Income | -$2,251 | -$5,458 | -$4,045 | -$5,628 |
| % Margin | -996% | -2,574.5% | -2,828.7% | -3,777.2% |
| EPS | -1.7 | -0.38 | -0.36 | -1.35 |
| % Growth | -347.4% | -5.6% | 73.3% | – |
| EPS Diluted | -1.7 | -0.38 | -0.36 | -1.35 |
| Weighted Avg Shares Out | 13,206 | 13,336 | 11,284 | 8,005 |
| Weighted Avg Shares Out Dil | 13,206 | 13,336 | 11,284 | 8,005 |
| Supplemental Information | – | – | – | – |
| Interest Income | $10 | $3 | $18 | $34 |
| Interest Expense | $83 | $67 | $49 | $51 |
| Depreciation & Amortization | $528 | $529 | $531 | $531 |
| EBITDA | -$1,655 | -$5,812 | -$4,189 | -$1,905 |
| % Margin | -732.3% | -2,741.5% | -2,929.4% | -1,278.5% |